Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0106213793
Mon, 31.08.2020
Polyphor AG
Allschwil, Switzerland and Shanghai, China, August 31, 2020
Polyphor and Fosun Pharma announce exclusive licensing agreement for balixafortide in China
- Fosun Pharma to lead clinical development and commercialization of balixafortide in metastatic breast cancer and potentially other cancers in China
- Polyphor to receive USD 15 million upfront [ … ]
Mon, 03.08.2020
Polyphor AG
Allschwil, Switzerland, August 3, 2020
Polyphor announces second positive Data Safety Monitoring Board recommendation to continue Phase III FORTRESS study without modifications
Polyphor AG (SIX: POLN) announced today that the Phase III clinical trial independent Data Safety Monitoring Board (DSMB) has completed the second, pre-specified interim a [ … ]
Tue, 28.07.2020
Polyphor AG
Allschwil, Switzerland, July 28, 2020
Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing
Polyphor AG (SIX: POLN) today announced that it has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over the period of two years. IRIS wi [ … ]